InsiderClue
← All stocks

SOPHiA GENETICS SA

SOPH Net selling
CIK 0001840706 #2827 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$748.63K
$629.77K on a plan · $79.44K straight out of an exercise
Sold at will
$39.42K
1 of 14 sales
Net
−$748.63K
−$39.42K against sales at will

By person

14 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Xu Zhenyu
Chief Scientific Officer
—
$284.12K (5) scheduled
−$284.12K
552,887
0.8073%
$4.36M
+2.8%
HIBBS KATHY L
Director
—
$105.05K (2) scheduled
−$105.05K
96,992
0.1416%
$764.72K
−0.3%
Verma Abhimanyu
Chief Technology Officer
—
$85.00K (2) scheduled
−$85.00K
172,171
0.2514%
$1.36M
+36.8%
Menu Philippe
Chief Medical Officer
—
$82.81K (2) scheduled
−$82.81K
208,387
0.3043%
$1.64M
+19.6%
Valente Manuela
Chief People Officer
—
$79.44K (1) scheduled
−$79.44K
210,450
0.3073%
$1.66M
+37.8%
Camblong Jurgi
Executive Chairman
—
$65.12K (1) scheduled
−$65.12K
3,435,822
5.02%
$27.09M
+3.9%
Van Well Daan
Chief Legal Officer
—
$47.09K (1) scheduled
−$47.09K
338,884
0.4948%
$2.67M
+29.4%
Muken Ross
Chief Executive Officer
—
—
—
670,651
0.9792%
$5.29M
+145.6%
Ossipow Vincent
Director
—
—
—
522,860
0.7635%
$4.12M
+3.9%
Cox Troy
Director
—
—
—
328,743
0.4800%
$2.59M
+6.4%
CARDOZA GEORGE
Chief Financial Officer
—
—
—
309,092
0.4513%
$2.44M
+66.5%
HIRSCH DIDIER
Director
—
—
—
240,220
0.3508%
$1.89M
+8.9%
Cossery Jean-Michel
Director
—
—
—
206,212
0.3011%
$1.63M
+10.6%
Puylaert Kevin
Chief Sales Officer
—
—
—
147,948
0.2160%
$1.17M
+60.1%

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Xu Zhenyu
14 Sep 2026
Chief Scientific Officer
Sold on a plan
4,000
$7.88
$31.54K
Van Well Daan
11 Sep 2026
Chief Legal Officer
Sold on a plan
6,168
$7.63
$47.09K
Camblong Jurgi
10 Sep 2026
Executive Chairman
Sold on a plan
8,500
$7.66
$65.12K
HIBBS KATHY L
8 Sep 2026
Director
Sold on a plan
6,250
$8.13
$50.82K
Xu Zhenyu
27 Aug 2026
Chief Scientific Officer
Sold on a plan
10,000
$8.91
$89.10K
HIBBS KATHY L
25 Aug 2026
Director
Sold on a plan
6,250
$8.68
$54.23K
Menu Philippe
25 Aug 2026
Chief Medical Officer
Sold on a plan
5,000
$8.68
$43.40K
Verma Abhimanyu
24 Aug 2026
Chief Technology Officer
Sold on a plan
5,000
$8.80
$44.00K
Xu Zhenyu
21 Aug 2026
Chief Scientific Officer
Sold on a plan
5,408
$8.40
$45.45K
Xu Zhenyu
20 Aug 2026
Chief Scientific Officer
Sold on a plan
4,592
$8.41
$38.61K
Verma Abhimanyu
19 Aug 2026
Chief Technology Officer
Sold on a plan
5,000
$8.20
$41.00K
Xu Zhenyu
19 Aug 2026
Chief Scientific Officer
Sold on a plan
10,000
$7.94
$79.43K
Show all 14 transactions →

What was left out

Form 4 filings counted 11
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 10,000
History held since 20 Mar 2026